These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2648253)

  • 1. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis.
    Lemoine NR; Mayall ES; Wyllie FS; Williams ED; Goyns M; Stringer B; Wynford-Thomas D
    Oncogene; 1989 Feb; 4(2):159-64. PubMed ID: 2648253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ha-ras oncogene (codon 12) mutation in thyroid carcinogenesis: analysis of 60 benign and malignant thyroid tumors.
    Bouras M; Parvaz P; Berger N; Paulin C; Revol A
    Ann Biol Clin (Paris); 1995; 53(10-11):549-55. PubMed ID: 8787281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of ras and gsp oncogene mutations in radiation-associated human thyroid tumors.
    Challeton C; Bounacer A; Du Villard JA; Caillou B; De Vathaire F; Monier R; Schlumberger M; Suárez HG
    Oncogene; 1995 Aug; 11(3):601-3. PubMed ID: 7630645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of mutations in all three ras genes in human thyroid tumors.
    Suarez HG; du Villard JA; Severino M; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
    Oncogene; 1990 Apr; 5(4):565-70. PubMed ID: 2183158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rates of ras codon 61 mutation in thyroid tumors in an iodide-deficient area.
    Shi YF; Zou MJ; Schmidt H; Juhasz F; Stensky V; Robb D; Farid NR
    Cancer Res; 1991 May; 51(10):2690-3. PubMed ID: 2021946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Demonstration of activated oncogenes of the ras family in human thyroid tumors using the polymerase chain reaction].
    Dockhorn-Dworniczak B; Caspari S; Schröder S; Böcker W; Dworniczak B
    Verh Dtsch Ges Pathol; 1990; 74():415-8. PubMed ID: 1708628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-associated and 'spontaneous' human thyroid carcinomas show a different pattern of ras oncogene mutation.
    Wright PA; Williams ED; Lemoine NR; Wynford-Thomas D
    Oncogene; 1991 Mar; 6(3):471-3. PubMed ID: 2011403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-ras 61 oncogene mutations in Hürthle cell tumors.
    Schark C; Fulton N; Jacoby RF; Westbrook CA; Straus FH; Kaplan EL
    Surgery; 1990 Dec; 108(6):994-9; discussion 999-1000. PubMed ID: 2247846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident.
    Nikiforov YE; Nikiforova MN; Gnepp DR; Fagin JA
    Oncogene; 1996 Aug; 13(4):687-93. PubMed ID: 8761289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of activated ras oncogenes in human thyroid carcinomas.
    Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
    Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.
    Bounacer A; Schlumberger M; Wicker R; Du-Villard JA; Caillou B; Sarasin A; Suárez HG
    Br J Cancer; 2000 Jan; 82(2):308-14. PubMed ID: 10646882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas.
    Vitagliano D; Portella G; Troncone G; Francione A; Rossi C; Bruno A; Giorgini A; Coluzzi S; Nappi TC; Rothstein JL; Pasquinelli R; Chiappetta G; Terracciano D; Macchia V; Melillo RM; Fusco A; Santoro M
    Oncogene; 2006 Aug; 25(39):5467-74. PubMed ID: 16785999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.
    Garcia-Rostan G; Zhao H; Camp RL; Pollan M; Herrero A; Pardo J; Wu R; Carcangiu ML; Costa J; Tallini G
    J Clin Oncol; 2003 Sep; 21(17):3226-35. PubMed ID: 12947056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular changes in the Ki-ras and APC genes in colorectal adenomas and carcinomas arising in the same patient.
    Zauber NP; Sabbath-Solitare M; Marotta SP; Zauber AG; Bishop DT
    J Pathol; 2001 Mar; 193(3):303-9. PubMed ID: 11241408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of Ha-ras (codon 12) proto-oncogene mutations in diverse thyroid cancers.
    Bouras M; Bertholon J; Dutrieux-Berger N; Parvaz P; Paulin C; Revol A
    Eur J Endocrinol; 1998 Aug; 139(2):209-16. PubMed ID: 9724079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
    Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
    Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ras oncogene mutations in benign and malignant thyroid neoplasms.
    Karga H; Lee JK; Vickery AL; Thor A; Gaz RD; Jameson JL
    J Clin Endocrinol Metab; 1991 Oct; 73(4):832-6. PubMed ID: 1890154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis.
    Namba H; Rubin SA; Fagin JA
    Mol Endocrinol; 1990 Oct; 4(10):1474-9. PubMed ID: 2283998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of activating mutations in ras and gsp oncogenes in a cohort of nine patients with sporadic pediatric thyroid tumors.
    Pauws E; Tummers RF; Ris-Stalpers C; de Vijlder JJ; Voûte T
    Med Pediatr Oncol; 2001 Jun; 36(6):630-4. PubMed ID: 11344494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.